CDC COCA Learn: May 4, 2018

View this email as a webpage: https://content.govdelivery.com/accounts/USCDC/bulletins/1ed5073

c o c a learn - c d c clinical outreach and communication activity

Upcoming COCA Call

Recommendations for the Use of Herpes Zoster Vaccines

Date: Thursday, May 10, 2018

Time: 2:00-3:00 PM (ET)

Herpes zoster, also referred to as shingles, is a common viral disease with approximately one million cases occurring each year in the United States. In October 2017, the Food and Drug Administration (FDA) approved a 2-dose, recombinant zoster vaccine ([RZV], Shingrix), for the prevention of herpes zoster in adults aged ≥50 years. The Centers for Disease Control and Prevention (CDC) recommends RZV for use in immunocompetent adults age ≥50 years. During this COCA Call, clinicians will learn about CDC recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine.

Recent COCA Call

RMSF tick

A Leopard without Spots: Clinical Diagnosis and Treatment of Rocky Mountain Spotted Fever

Rocky Mountain spotted fever (RMSF), a life-threatening and rapidly progressive tickborne disease, is caused by infection from the bacterium Rickettsia rickettsii. Infection begins with non-specific symptoms like fever, headache, and muscle pain, but unmitigated damage to the vascular endothelium quickly results in organ failure, necrosis, and ultimately death. Early clinical diagnosis is key—as treatment within the first 5 days of illness has been associated with lower mortality. Additionally, newer diagnostics are now available that can aid in early detection. RMSF is a recently-emerging pathogen in Arizona and along the U.S.-Mexico border region. Case fatality rates in these regions have been extremely high and closely tied to widespread tick and free-roaming dog populations. During this COCA call, clinicians discussed the detection, diagnosis, and epidemiology of RMSF.

Archived COCA conference calls are available here. Free continuing education available for most COCA calls. More information about free CE is available here.

Emergency Preparedness and Response Training Resources

    Emergency Preparedness and Response

    This page features scheduled and on-demand access information on emergency preparedness and response training resources that CDC, other federal agencies, and COCA partners offer.

    Radiation Emergencies: Information for Clinicians

    Emergency services physicians and nurses will be among the first clinicians to see and treat victims of radiation emergencies. Clinicians of all specialties will be responsible for providing care and information to those involved. Visit this webpage to access information on patient management, guidelines and recommendations, and trainings that CDC provides for radiation emergencies.  

      Conference and Training Opportunities

      Trainings

      The Conference and Training Opportunities webpage has been updated to include conferences from May 2018–October 2018. Visit the webpage to learn about conferences that CDC, other federal agencies, and COCA partners sponsor.

      May COCA Partner Spotlight

      COCA Partner

      COCA is pleased to feature the American Nurses Association (ANA) in our May COCA Partner Spotlight. 

      ANA exists to advance the nursing profession by fostering high standards of nursing practice, promoting a safe and ethical work environment, bolstering the health and wellness of nurses, and advocating on health care issues that affect nurses and the public. Partnerships with professional healthcare associations are vital to CDC’s ability to share information with clinicians about public health emergencies, CDC guidance, health alert messages, and training opportunities.

      Learn more about ANA from their website and follow them on Facebook.

      Training Opportunities

      FDA Drug Topics: Protecting Patients – Pharmacists Requirements under the Drug Supply Chain Security Act

      This series of educational webinars is designed to aid physicians, physician assistants, nurses, pharmacists, pharmacy technicians, other health care professionals, and students to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. To register for the webinar, please visit this page.

      Date: May 8, 2018

      Time: 1:00-2:00 PM (ET) 

       Vital Signs Town Hall - Vector-Borne Diseases: The Growing Threat

      The Town Hall for May will highlight the upcoming Vital Signs report, which will focus on the growing threat of mosquito and tick-borne diseases. The experts will discuss the findings in the newly released report, and partners from the field will discuss approaches, challenges, and successes in addressing this issue. Please visit the Vital Signs Town Hall Teleconferences webpage to learn how to join the call.

      Date: May 8, 2018

      Time: 2:00-3:00 PM (ET)


      Learn about Antibiotic Resistance Laboratory Testing and Resources

      Laboratory tests can help guide patient treatment, detect emerging threats, and prevent the spread of antibiotic resistance. CDC’s Antibiotic Resistance Laboratory Network (AR Lab Network) supports nationwide lab capacity to:

      • Rapidly detect antibiotic resistance in healthcare, food, and the community, and
      • Inform local responses to prevent spread and protect people.

      FDA Overview of Biosimilar Products  

      This continuing education (CE) course provides an understanding of biological products and biosimilar products and a description of FDA’s general approach to the development and approval of biosimilar products.

      1918 Pandemic Flu Symposium Registration

      On May 7, 2018, CDC and Emory University’s Rollins School of Public Health are hosting a one-day symposium. One hundred years after the 1918 flu pandemic, experts from academia and government will discuss current pandemic flu threats and the future of pandemic preparedness. Registration for the live webcast is now open.

      Register for Upcoming June ACIP Meeting

      The Advisory Committee on Immunization Practices (ACIP) comprises medical and public health experts who develop recommendations on the use of vaccines in the civilian population of the United States. The recommendations stand as public health guidance for safe use of vaccines and related biological products.

      Date & Time: June 20-21, 2018, 7:00 AM - 6:00 PM (ET)

      Meeting Location: CDC, Tom Harkin Global Communications Center, Kent 'Oz' Nelson Auditorium

      Deadline for registration for in-person attendance to the ACIP Meeting:

      • Non-US Citizens: May 16, 2018
      • US Citizens: June 11, 2018
      • Registration is NOT required to watch the live meeting webcast or to listen via telephone. 

      CDC ZOHU Calls/Webinars

      Zoonoses & One Health Updates (ZOHU) Calls are one hour monthly webinars that provide timely education on zoonotic and infectious diseases, One Health, and related health threats at the animal-human-ecosystem interface. Continuing Education is available for most calls/webinars

      cdc train

      CDC TRAIN

      CDC TRAIN provides access to more than 1,000 courses that CDC programs, grantees, and other funded partners have developed. Courses offered by CDC course providers have been approved and verified by CDC.

      CDC Grand Rounds on Antibiotics Aware: Smart Use, Best Care

      Public Health Grand Rounds is a monthly webcast created to foster discussion on major public health issues.The Grand Rounds sessions also highlight how CDC and its partners are already addressing these challenges and discuss recommendations for future research and practice. Visit Grand Rounds On-Demand to browse previous presentations.

      Date: Tuesday, May 15, 2018

      Time: 1:00-2:00 PM (ET)

      Learning Connection

      CDC Learning Connection for May

      • Women and Opioids: In honor of National Women’s Health Week (May 13-19), learn about unique considerations regarding opioid use among women with the latest courses on TRAIN. 
      • Antibiotic resistance is a serious public health threat. Take “CDC Training on Antibiotic Stewardship: Section 1” and learn how to optimize antibiotic use to protect patients and combat resistance. Free CE.
      • Looking for an introduction to epidemiology or just a refresher? Take “Boots on the Ground Part 1: Foundational Epidemiology,” a course from CDC’s Public Health Associate Program.
      • This Hepatitis Awareness Month, complete “You Call the Shots: Hepatitis A Immunization” to learn about the disease, groups at highest risk, and vaccination recommendations. Free CE.

      • Sign up for the free monthly e-newsletter to stay up-to-date on similar public health learning opportunities from CDC, other federal agencies, and federally funded partners.

      Clinician's Corner Featuring Kathleen Dooling, MD, MPH

      Dr. Dooling

      Welcome to the Clinician’s Corner! Each month we feature a CDC clinician or a clinician who has presented on a COCA call. This month, we’re excited to feature Dr. Kathleen Dooling.

      Dr. Dooling is a Medical Officer with CDC's National Center for Immunization and Respiratory Diseases. She is the Lead Medical Officer for the Advisory Committee on Immunization Practices (ACIP) Herpes Zoster Workgroup. She recently authored the Recommendations of the ACIP for Use of Herpes Zoster Vaccines. Dr. Dooling is the host of CDC’s Morbidity and Mortality Weekly Report weekly podcast, which discusses current public health problems in plain language.

      Dr. Dooling will be the presenter on an upcoming COCA Call, Recommendations for the Use of Herpes Zoster Vaccines, on Thursday, May 10, where she will discuss CDC's recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine. Be sure to check it out and get free Continuing Education (CE).